Neurotrope (NTRP) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.73 | 1.57 | 0.33 | 0.06 | -0.15 | ||||
| Changes by years, y/y, % | -37% | +116% | -79% | -100% | -45.5% | ||||
Neurotrope. Debt/EBITDA
Neurotrope. Debt/EBITDA, changes, %
Neurotrope (NTRP) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | 2026Q3 | LTM ? | |||
| Debt/EBITDA | -0.43 | 0.07 | -0.25 | -0.17 | -0.15 | -0.15 | ||
| Changes by years, y/y, % | -70% | -219% | -65% | |||||
| Changes by quarters, q/q, % | +592% | -117% | -433% | -33% | -9% | |||